Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001651431-19-000005
Filing Date
2019-08-20
Accepted
2019-08-20 15:13:06
Documents
1
Effectiveness Date
2019-08-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12549
  Complete submission text file 0001651431-19-000005.txt   13614
Mailing Address 101 MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142
Business Address 101 MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-347004 | Film No.: 191039075